Hyaluronan
Sponsors
Mesoblast International Sàrl, Mesoblast, Ltd., Hadassah Medical Organization, Pierre Fabre Medicament, Laval University
Conditions
Anterior Cruciate Ligament InjuryGastrointestinal MicrobiomeHip OsteoarthritisInterdental Papilla AugmentationKnee OsteoarthritisOsteoarthritisRecovery Following Partial Medial MeniscectomyTissue Adhesions
Early Phase 1
Phase 1
A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
CompletedNCT00225095
Start: 2005-09-30End: 2008-04-30Updated: 2021-12-27
Safety and Efficacy Study of MSB-CAR001 in Subjects 6 Weeks Post an Anterior Cruciate Ligament Reconstruction
CompletedNCT01088191
Start: 2009-03-31End: 2014-10-31Updated: 2018-08-15
Phase 2
Phase 4
Unknown Phase
Efficacy and Safety Study in Patients Suffering From Knee Osteoarthritis
WithdrawnNCT01469507
Updated: 2013-02-21
Minimally Invasive Volume Augmentation of Papillae Around Implant Restorations With Hyaluronic Acid Injection
CompletedNCT02536807
Start: 2014-08-31End: 2016-05-31Updated: 2016-09-20
Human Pilot Study - HA35 (Hyaluronan Molecular Weight 35) Dietary Supplement for Promoting Intestinal Health
CompletedNCT02867605
Start: 2016-07-31End: 2019-06-20Updated: 2020-09-03